This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....